Taylor Schumann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Taylor Schumann has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Ballard Massenburg
University of California San Diego, CA, USA
1 shared publication Bianca Di Chiaro
Division of Plastic and Reconstructive Surgery, Department of Surgery, Loyola University Medical Center, Maywood, IL, USA
1 shared publication- Christopher Kujalowicz
Division of Plastic and Reconstructive Surgery, Department of Surgery, Loyola University Stritch School of Medicine, Maywood, IL, USA
1 shared publication - Dane Salazar
Department of Orthopaedic Surgery, Loyola University Hospital System, Maywood, Illinois
1 shared publication - Eleanor Bucholz
Division of Plastic and Reconstructive Surgery, Department of Surgery, Loyola University Medical Center, Maywood, IL, USA
1 shared publication - Irena Helenowski
Clinical Research Office, Loyola University Chicago, Maywood, IL 60153, USA
1 shared publication
Latest Publications
- Open Access
- 8 September 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (10) , 6283-6288
Risks of free flap reconstruction amongst smoking patients: a NSQIP analysis of 4653 patients from 2010 to 2021
Background: Microvascular free flap reconstruction for complex soft tissue defects relies on vascular perfusion for overall flap survival. Smoking has been linked to complications in postoperative wound healing due to vasoconstriction and weakened immune status. We aim to investigate the impact of smoking on postoperative complications in patients undergoing free flap reconstructive surgery. Methods: Using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database, adult patients (≥18 years old) undergoing microvascular free flap surgery (Current Procedural Terminology: 15 756–15 758) from 2010 to 2021 were included. Patients were excluded if they were P = 0.024) and wound disruption (OR = 1.597, 95% CI: 1.092–2.336, P = 0.016). There were no significant differences in rates of superficial or deep incisional SSIs, graft/flap failure, sepsis/septic shock, or venous thromboembolism. Conclusion: Smoking was associated with increased rates of organ/space surgical site infections and wound dehiscence, but not with flap failure in patients undergoing microvascular free flap reconstruction. These findings support the role of preoperative smoking cessation counseling and more nuanced risk stratification focused on wound-related complications rather than flap survival.
- 8 September 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (10) , 6283-6288
Open AccessRisks of free flap reconstruction amongst smoking patients: a NSQIP analysis of 4653 patients from 2010 to 2021
Background: Microvascular free flap reconstruction for complex soft tissue defects relies on vascular perfusion for overall flap survival. Smoking has been linked to complications in postoperative wound healing due to vasoconstriction and weakened immune status. We aim to investigate the impact of smoking on postoperative complications in patients undergoing free flap reconstructive surgery. Methods: Using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database, adult patients (≥18 years old) undergoing microvascular free flap surgery (Current Procedural Terminology: 15 756–15 758) from 2010 to 2021 were included. Patients were excluded if they were P = 0.024) and wound disruption (OR = 1.597, 95% CI: 1.092–2.336, P = 0.016). There were no significant differences in rates of superficial or deep incisional SSIs, graft/flap failure, sepsis/septic shock, or venous thromboembolism. Conclusion: Smoking was associated with increased rates of organ/space surgical site infections and wound dehiscence, but not with flap failure in patients undergoing microvascular free flap reconstruction. These findings support the role of preoperative smoking cessation counseling and more nuanced risk stratification focused on wound-related complications rather than flap survival.
- 25 July 2026
- Published by SAGE Publications in Face
- Vol. 7 (4) , 530-539
Use of Perioperative Antibiotics in Cleft Lip and Palate Surgery: A Systematic Review
Background: Orofacial clefts are the most common craniofacial birth defect and present significant functional and esthetic challenges. Surgical repair is essential, with prevention of complications, particularly infection, fistula, and dehiscence, being critical. The role of perioperative antibiotics in reducing these complications remains unclear, with conflicting evidence in the literature. This systematic review evaluates the effect of perioperative antibiotics on complication rates in cleft lip repair, palatoplasty, and alveolar bone grafting. Methods: Medline, Embase, EBM, and Web of Science were searched from 1995 to 2025. Eligible studies evaluated perioperative antibiotic use in cleft procedures and included a comparator group. Non-English studies and those lacking treatment outcomes were excluded. Results: Ten studies met inclusion criteria. Six investigated palatoplasty, 2 included cleft lip and palate repair, and 2 examined alveolar bone grafting. Considerable variability was noted in antibiotic regimen, timing, and outcome reporting. Across procedures, prophylactic or prolonged antibiotic use was not associated with reduced complications. In cleft lip repair, infection occurred in 4.2% (n = 3/72) with no reduction from antibiotics. In palatoplasty, fistula occurred in 8.2% (n = 283/3457) with no benefit of extended antibiotics. In alveolar bone grafting, graft loss occurred in 2.7% (n = 5/185) without advantage from prolonged use. Conclusions: Current evidence does not support perioperative antibiotics as effective in reducing infection, fistula, or graft loss in cleft surgery, however existing research quality is low. Standardized, high-quality comparative studies are needed to better define their role in perioperative management.
- 25 July 2026
- Published by SAGE Publications in Face
- Vol. 7 (4) , 530-539
Use of Perioperative Antibiotics in Cleft Lip and Palate Surgery: A Systematic Review
Background: Orofacial clefts are the most common craniofacial birth defect and present significant functional and esthetic challenges. Surgical repair is essential, with prevention of complications, particularly infection, fistula, and dehiscence, being critical. The role of perioperative antibiotics in reducing these complications remains unclear, with conflicting evidence in the literature. This systematic review evaluates the effect of perioperative antibiotics on complication rates in cleft lip repair, palatoplasty, and alveolar bone grafting. Methods: Medline, Embase, EBM, and Web of Science were searched from 1995 to 2025. Eligible studies evaluated perioperative antibiotic use in cleft procedures and included a comparator group. Non-English studies and those lacking treatment outcomes were excluded. Results: Ten studies met inclusion criteria. Six investigated palatoplasty, 2 included cleft lip and palate repair, and 2 examined alveolar bone grafting. Considerable variability was noted in antibiotic regimen, timing, and outcome reporting. Across procedures, prophylactic or prolonged antibiotic use was not associated with reduced complications. In cleft lip repair, infection occurred in 4.2% (n = 3/72) with no reduction from antibiotics. In palatoplasty, fistula occurred in 8.2% (n = 283/3457) with no benefit of extended antibiotics. In alveolar bone grafting, graft loss occurred in 2.7% (n = 5/185) without advantage from prolonged use. Conclusions: Current evidence does not support perioperative antibiotics as effective in reducing infection, fistula, or graft loss in cleft surgery, however existing research quality is low. Standardized, high-quality comparative studies are needed to better define their role in perioperative management.
- 1 July 2026
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 16 (3)
Bilateral Distal Myotendinous Biceps Ruptures
Case: A 41-year-old man presented with bilateral distal biceps tendon ruptures at the distal myotendinous junction, sustained in 2 separate incidents 15 months apart. This injury pattern is rare and differs from the more common avulsion from the radial tuberosity. Initial imaging was inconclusive, and the diagnosis was aided by physical examination. He elected to undergo open repair of the right side after persistent weakness with elbow flexion and supination. Conclusion: This case illustrates an uncommon location of distal biceps rupture and emphasizes the importance of careful clinical evaluation, surgical decision-making, and focused rehabilitation to achieve functional recovery.
- 1 July 2026
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 16 (3)
Bilateral Distal Myotendinous Biceps Ruptures
Case: A 41-year-old man presented with bilateral distal biceps tendon ruptures at the distal myotendinous junction, sustained in 2 separate incidents 15 months apart. This injury pattern is rare and differs from the more common avulsion from the radial tuberosity. Initial imaging was inconclusive, and the diagnosis was aided by physical examination. He elected to undergo open repair of the right side after persistent weakness with elbow flexion and supination. Conclusion: This case illustrates an uncommon location of distal biceps rupture and emphasizes the importance of careful clinical evaluation, surgical decision-making, and focused rehabilitation to achieve functional recovery.